The key trends fueling Chimera 2030 CIMP growth potential Momentum Building 20260506 Why Versamet VMET might be the steady performer you need Trend Strengthens 20260506 Why Cadre CDRE is still under the radar On the Radar 20260508 FENC Fennec Pharmaceuticals posts far wider than expected Q4 2025 loss even as shares tick higher